Literature DB >> 31129138

RETRACTED: Ras-ERK1/2 signaling accelerates the progression of colorectal cancer via mediation of H2BK5ac.

Huanxiang Jia1, Ming Xu2, Yan Bo3, Wenxiao Li4, Runhe Zhou5.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments of Dr Elisabeth Bik regarding this article “… the Western blot bands in all 400+ papers are all very regularly spaced and have a smooth appearance in the shape of a dumbbell or tadpole, without any of the usual smudges or stains. All bands are placed on similar looking backgrounds, suggesting they were copy/pasted from other sources, or computer generated”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  ATF2; Colorectal cancer; H2BK5ac; HDAC2; MDM2; Ras-ERK1/2

Mesh:

Substances:

Year:  2019        PMID: 31129138     DOI: 10.1016/j.lfs.2019.05.060

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development.

Authors:  Jeong-Ryul Hwang; Yeongseon Byeon; Donghwan Kim; Sung-Gyoo Park
Journal:  Exp Mol Med       Date:  2020-05-21       Impact factor: 8.718

2.  Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells.

Authors:  Robert J Rabelo-Fernández; Ginette S Santiago-Sánchez; Rohit K Sharma; Abiel Roche-Lima; Kelvin Carrasquillo Carrion; Ricardo A Noriega Rivera; Blanca I Quiñones-Díaz; Swetha Rajasekaran; Jalal Siddiqui; Wayne Miles; Yasmarie Santana Rivera; Fatima Valiyeva; Pablo E Vivas-Mejia
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 6.208

Review 3.  T cell receptor (TCR) signaling in health and disease.

Authors:  Kinjal Shah; Amr Al-Haidari; Jianmin Sun; Julhash U Kazi
Journal:  Signal Transduct Target Ther       Date:  2021-12-13

4.  Rapamycin inhibits oral cancer cell growth by promoting oxidative stress and suppressing ERK1/2, NF-κB and beta-catenin pathways.

Authors:  Abdelhabib Semlali; Sofia Papadakos; Camille Contant; Ikram Zouaoui; Mahmoud Rouabhia
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.